139 related articles for article (PubMed ID: 28713058)
1. Regression of unusual optic disk neovascularization after adalimumab in a case of juvenile idiopathic arthritis-related uveitis.
Interlandi E; Latanza L; Pellegrini F; Pavesio C
J AAPOS; 2017 Oct; 21(5):412-414. PubMed ID: 28713058
[TBL] [Abstract][Full Text] [Related]
2. [A case of panuveitis with optic disc neovascularization associated with juvenile idiopathic arthritis which progressed during a clinical trial of etanercept].
Kinouchi R; Hirokawa H; Igarashi S; Fukui K; Hirano Y; Takai Y; Yoshida A
Nippon Ganka Gakkai Zasshi; 2007 Dec; 111(12):970-5. PubMed ID: 18186220
[TBL] [Abstract][Full Text] [Related]
3. Adalimumab for juvenile idiopathic arthritis-associated uveitis.
Magli A; Forte R; Navarro P; Russo G; Orlando F; Latanza L; Alessio M
Graefes Arch Clin Exp Ophthalmol; 2013 Jun; 251(6):1601-6. PubMed ID: 23446556
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.
Heiligenhaus A; Klotsche J; Tappeiner C; Sengler C; Niewerth M; Liedmann I; Hoeft S; Walscheid K; Lavric M; Foell D; Minden K
Rheumatology (Oxford); 2019 Jun; 58(6):975-986. PubMed ID: 30590748
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series.
La Torre F; Cattalini M; Teruzzi B; Meini A; Moramarco F; Iannone F
BMC Res Notes; 2014 May; 7():316. PubMed ID: 24886032
[TBL] [Abstract][Full Text] [Related]
6. Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis.
Correll CK; Bullock DR; Cafferty RM; Vehe RK
Clin Rheumatol; 2018 Feb; 37(2):549-553. PubMed ID: 29103180
[TBL] [Abstract][Full Text] [Related]
7. Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease.
Giansanti F; Barbera ML; Virgili G; Pieri B; Emmi L; Menchini U
Eur J Ophthalmol; 2004; 14(5):445-8. PubMed ID: 15506610
[TBL] [Abstract][Full Text] [Related]
8. Optic disk neovascularization in juvenile rheumatoid arthritis.
Semple HC; Landers MB; Morse LS
Am J Ophthalmol; 1990 Aug; 110(2):210-2. PubMed ID: 1696068
[No Abstract] [Full Text] [Related]
9. [Preretinal neovessels in toxoplasmic uveitis].
Gaudric A; Pelosse B; Coscas G
J Fr Ophtalmol; 1983; 6(5):481-6. PubMed ID: 6195208
[TBL] [Abstract][Full Text] [Related]
10. LONG-TERM OUTCOMES OF RITUXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS POSTERIOR UVEITIS REFRACTORY TO CONVENTIONAL IMMUNOSUPPRESSIVE THERAPY.
Lasave AF; You C; Ma L; Abusamra K; Lamba N; Valdes Navarro M; Meese H; Foster CS
Retina; 2018 Feb; 38(2):395-402. PubMed ID: 28225369
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and therapy of uveitis in childhood].
Kiss J; Gaál V; Nyul Z; Mosdósi B
Orv Hetil; 2019 Aug; 160(34):1335-1339. PubMed ID: 31423830
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis.
Breitbach M; Tappeiner C; Böhm MR; Zurek-Imhoff B; Heinz C; Thanos S; Ganser G; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):171-177. PubMed ID: 27687987
[TBL] [Abstract][Full Text] [Related]
13. Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.
Acharya NR; Ebert CD; Kelly NK; Porco TC; Ramanan AV; Arnold BF;
Trials; 2020 Oct; 21(1):887. PubMed ID: 33109240
[TBL] [Abstract][Full Text] [Related]
14. Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.
Leinonen ST; Aalto K; Kotaniemi KM; Kivelä TT
Clin Exp Rheumatol; 2017; 35(6):1043-1046. PubMed ID: 29148422
[TBL] [Abstract][Full Text] [Related]
15. Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis.
Skrabl-Baumgartner A; Seidel G; Langner-Wegscheider B; Schlagenhauf A; Jahnel J
Arch Dis Child; 2019 Mar; 104(3):246-250. PubMed ID: 30026253
[TBL] [Abstract][Full Text] [Related]
16. Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial.
Horton S; Jones AP; Guly CM; Hardwick B; Beresford MW; Lee RW; Dick AD; Ramanan AV
Am J Ophthalmol; 2019 Nov; 207():170-174. PubMed ID: 31201796
[TBL] [Abstract][Full Text] [Related]
17. Presumed tubercular choroidal nodule following adalimumab therapy for juvenile idiopathic arthritis.
Vaidya H; Dutta Majumder P; Biswas J
Indian J Ophthalmol; 2019 Mar; 67(3):399-400. PubMed ID: 30777964
[No Abstract] [Full Text] [Related]
18. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
Klotsche J; Niewerth M; Haas JP; Huppertz HI; Zink A; Horneff G; Minden K
Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155
[TBL] [Abstract][Full Text] [Related]
19. Steroid responsive disc neovascularisation in uveitis associated with juvenile chronic arthritis.
Gray T; Kanski J; Lightman S
Br J Ophthalmol; 1998 Mar; 82(3):327-8. PubMed ID: 9602637
[No Abstract] [Full Text] [Related]
20. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
Deitch I; Amer R; Tomkins-Netzer O; Habot-Wilner Z; Friling R; Neumann R; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
